Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain

dc.contributor.authorRomero Gómez, Manuel 1967-
dc.contributor.authorKachru, Nandita
dc.contributor.authorAscanio, Meritxell
dc.contributor.authorDarbà, Josep
dc.contributor.authorShreay, Sanatan
dc.date.accessioned2021-03-19T12:20:02Z
dc.date.available2021-03-19T12:20:02Z
dc.date.issued2020-12-11
dc.date.updated2021-03-19T12:20:02Z
dc.description.abstractThe rising prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) presents many public health challenges, including a substantial impact on healthcare resource utilization and costs. There are important regional differences in the burden of NAFLD/NASH, and Spain-specific data are lacking. This retrospective, observational study examined the impact of liver disease severity, comorbidities, and demographics on healthcare resource utilization and costs in Spain (...)
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec705274
dc.identifier.issn0025-7974
dc.identifier.urihttps://hdl.handle.net/2445/175433
dc.language.isoeng
dc.publisherLippincott, Williams & Wilkins. Wolters Kluwer Health
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1097/MD.0000000000023506
dc.relation.ispartofMedicine, 2020, vol. 99, num. 50, p. e23506
dc.relation.urihttps://doi.org/10.1097/MD.0000000000023506
dc.rightscc-by (c) Romero Gómez, Manuel 1967- et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Economia)
dc.subject.classificationCost de l'assistència sanitària
dc.subject.classificationGestió hospitalària
dc.subject.classificationHepatitis
dc.subject.classificationMalalties del fetge
dc.subject.otherCost of medical care
dc.subject.otherHospital administration
dc.subject.otherHepatitis
dc.subject.otherLiver diseases
dc.titleDisease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
705274.pdf
Mida:
464.72 KB
Format:
Adobe Portable Document Format